Japan has approved the Novavax vaccine for COVID-19

Japan’s health ministry committee said it approved Novavax’s COVID-19 vaccine, paving the way for full approval of the country’s fourth coronavirus vaccine. The Japanese government has agreed to purchase 150 million doses of Novavax, a recombinant protein vaccine.

Share this post:

Share on facebook
Share on twitter
Share on pinterest
Share on whatsapp
Related Posts
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore
WordPress Cookie Plugin by Real Cookie Banner